|Quantity Discounts||1 - 9999|
|1 - 9999|
China need not remain a mystery.
If your company wants to enter the Chinese market, this is the resource you need — a step-by-step guide through the maze of Chinese drug import policies and procedures, written in the language you speak: English, plain and simple. You’ll discover:
The China Pharmaceutical Guidebook: 2013 is really four books in one:
Vol. I, Latest Chinese Regulations for Imported Drug Registration, spells out how to register imported drugs with China’s Food and Drug Administration (CFDA). An inside look at Chinese rules and procedures, Vol. I features:
You’ll want to order Volume I for certain, then supplement it as appropriate with any or all of three companion volumes:
Each volume is $750 per copy, delivered electronically as a PDF file.
China’s regulatory system is complex and lacks the transparency you expect as a U.S. drugmaker. Language and cultural differences further muddy the waters. Why risk missteps? Get ready now for the China boom-to-end-all-booms. Order your copies of China Pharmaceutical Guidebook: 2013.
China Pharmaceutical Guidebook: 2013 is created and published by Access China Management Consulting Ltd., a specialist in providing guidance to foreign manufacturers seeking entry to the China market; and distributed by FDAnews. China Pharmaceutical Guidebook: 2013 is available online in PDF format only. Each volume is $750 per single copy, delivered instantaneously via email.
Your purchase is nonrefundable. All sales are final.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing